LRRC32 antibody (AA 240-269)
Quick Overview for LRRC32 antibody (AA 240-269) (ABIN453046)
Target
See all LRRC32 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 240-269
-
Specificity
- This antibody detects GARP at Center.
-
Cross-Reactivity (Details)
- Species reactivity (tested):Human, Mouse.
-
Purification
- Prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS
-
Immunogen
- KLH conjugated synthetic peptide between 240~269 amino acids from the Center region of Human GARP Genename: LRRC32
-
-
-
-
Application Notes
-
Western blot: 1: 50 - 1: 100. ELISA: 1: 1,000. Immunohistochemistry on paraffin sections: 1: 10 - 1: 50.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS, 0.09 % (W/V) Sodium Azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- LRRC32 (Leucine Rich Repeat Containing 32 (LRRC32))
-
Alternative Name
- LRRC32 / GARP
-
Background
- GARP, also known as leucine rich repeat containing 32, is a type I membrane protein with twenty-two leucine-rich repeats and a short intracytoplasmic region. GARP was identified based on the analysis of gene expression profiling of Treg and Th cells following TCR stimulation. Since GARP is expressed in CD4+, CD25+, FoxP3+ cells (Tregs), it may be a candidate for cell surface marker for Treg cells.Synonyms: D11S833E, Garpin, Glycoprotein A repetitions predominant, Leucine-rich repeat-containing protein 32
-
Molecular Weight
- 71979 Da
-
Gene ID
- 2615
-
NCBI Accession
- NP_001122394
-
UniProt
- Q14392
-
Pathways
- Activated T Cell Proliferation
Target
-